Medtronic Inc. (MDT) | Common-Size Statement of Financial Position, Liabilities and Stockholders' Equity
See also
- Johnson & Johnson (JNJ), Common-Size Liabilities and Stockholders' Equity
- Pfizer Inc. (PFE), Common-Size Liabilities and Stockholders' Equity
- Novartis AG (NVS), Common-Size Liabilities and Stockholders' Equity
- Merck & Co. Inc. (MRK), Common-Size Liabilities and Stockholders' Equity
- GlaxoSmithKline PLC (GSK), Common-Size Liabilities and Stockholders' Equity
- Abbott Laboratories (ABT), Common-Size Liabilities and Stockholders' Equity
- Sanofi (SNY), Common-Size Liabilities and Stockholders' Equity
- Novo Nordisk A/S (NVO), Common-Size Liabilities and Stockholders' Equity
- UnitedHealth Group Inc. (UNH), Common-Size Liabilities and Stockholders' Equity
- Bristol-Myers Squibb Co. (BMY), Common-Size Liabilities and Stockholders' Equity
- AstraZeneca PLC (AZN), Common-Size Liabilities and Stockholders' Equity
- Eli Lilly & Co. (LLY), Common-Size Liabilities and Stockholders' Equity
- Baxter International Inc. (BAX), Common-Size Liabilities and Stockholders' Equity
ˇ Show More
You have visited 10 password protected pages for free. Others contain data covered by 
.
Sign Up Now to get full access to whole website and cut out all advertisements.
Medtronic Inc., Common-Size Consolidated Statement of Financial Position, Liabilities and Stockholders' Equity
| Apr 29, 2011 | Apr 30, 2010 | Apr 24, 2009 | Apr 25, 2008 | Apr 27, 2007 | Apr 28, 2006 | ||
|---|---|---|---|---|---|---|---|
 |
Short-term borrowings | |
|
|
|
|
|
|
Accounts payable | |
|
|
|
|
|
|
Accrued compensation | |
|
|
|
|
|
|
Accrued income taxes | |
|
|
|
|
|
|
Other accrued expenses | |
|
|
|
|
|
|
Current liabilities | % |
% |
% |
% |
% |
% |
|
Long-term debt | |
|
|
|
|
|
|
Long-term accrued compensation and retirement benefits | |
|
|
|
|
|
|
Long-term accrued income taxes | |
|
|
|
|
|
|
Long-term deferred tax liabilities, net | |
|
|
|
|
|
|
Other long-term liabilities | |
|
|
|
|
|
|
Non-current liabilities | % |
% |
% |
% |
% |
% |
|
Total liabilities | % |
% |
% |
% |
% |
% |
|
Preferred stock; par value $1.00 | |
|
|
|
|
|
|
Common stock; par value $0.10 | |
|
|
|
|
|
|
Retained earnings | |
|
|
|
|
|
|
Accumulated other comprehensive loss | |
|
|
|
|
|
|
Shareholders’ equity | % |
% |
% |
% |
% |
% |
|
Total liabilities and shareholders’ equity | % |
% |
% |
% |
% |
% |
Stock Analysis on Net (www.stock-analysis-on.net)
Copyright © 2012 EBIT Financial Analyses Center